Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice

被引：6
|
作者：
Froberg, Gabrielle [1 ,2 ]
Jansson, Lena [1 ]
Bruchfeld, Judith [1 ,2 ]
机构：
[1] Karolinska Univ Hosp, Dept Infect Dis, B2 00, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Div Infect Dis, Dept Med Solna, Stockholm, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 53卷 / 02期
关键词：
INFECTION; RIFAPENTINE;
D O I：
10.1183/13993003.01128-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Rifapentine and Isoniazid for Latent Tuberculosis
    Mirsaeidi, Mehdi
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1447 - 1448
  • [2] Rifapentine and Isoniazid for Latent Tuberculosis REPLY
    Sterling, Timothy R.
    Moro, Ruth
    Villarino, M. Elsa
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1448 - 1448
  • [3] Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
    Sterling, Timothy R.
    Villarino, M. Elsa
    Borisov, Andrey S.
    Shang, Nong
    Gordin, Fred
    Bliven-Sizemore, Erin
    Hackman, Judith
    Hamilton, Carol Dukes
    Menzies, Dick
    Kerrigan, Amy
    Weis, Stephen E.
    Weiner, Marc
    Wing, Diane
    Conde, Marcus B.
    Bozeman, Lorna
    Horsburgh, C. Robert, Jr.
    Chaisson, Richard E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23): : 2155 - 2166
  • [4] Rifapentine for the treatment of latent tuberculosis
    Egelund, Eric F.
    Peloquin, Charles A.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (10) : 1253 - 1261
  • [5] COMBINED USE OF ISONIAZID AND RIFAPENTINE IN THE TREATMENT OF LATENT TUBERCULOSIS: A BUDGET IMPACT ANALYSIS
    Sena, R. R.
    Wichmann, R. M.
    Silva, M. T.
    VALUE IN HEALTH, 2017, 20 (09) : A928 - A928
  • [6] Pharmacokinetics of isoniazid and rifapentine in young pediatric patients with latent tuberculosis infection
    Phaisal, Weeraya
    Jantarabenjakul, Watsamon
    Wacharachaisurapol, Noppadol
    Tawan, Monta
    Puthanakit, Thanyawee
    Wittayalertpanya, Supeecha
    Chariyavilaskul, Pajaree
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 725 - 732
  • [7] Use of Rifapentine and Isoniazid Directly Observed Therapy for the Treatment of Latent Tuberculosis Infection in a Military Clinic
    Jinbo, Janelle
    Lustik, Michael
    West, Gordon F.
    Kloetzel, Megan
    MILITARY MEDICINE, 2017, 182 (9-10) : E2024 - E2029
  • [8] High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection
    Sandul, Amy L.
    Nwana, Nwabunie
    Holcombe, Mike
    Lobato, Mark N.
    Marks, Suzanne
    Webb, Risa
    Wang, Shu-Hua
    Stewart, Brock
    Griffin, Phil
    Hunt, Garrett
    Shah, Neha
    Marco, Asween
    Patil, Naveen
    Mukasa, Leonard
    Moro, Ruth N.
    Jereb, John
    Mase, Sundari
    Chorba, Terence
    Bamrah-Morris, Sapna
    Ho, Christine S.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (07) : 1085 - 1093
  • [9] High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons
    Schmit, Kristine M.
    Lobato, Mark N.
    Lang, Simona G.
    Wheeler, Sherri
    Kendig, Newton E.
    Bur, Sarah
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2019, 25 (02): : E1 - E6
  • [10] Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection
    Weiner, Marc
    Savic, Radojka M.
    Mac Kenzie, Awilliam R.
    Wing, Diane
    Peloquin, Charles A.
    Engle, Melissa
    Bliven, Erin
    Prihoda, Thomas J.
    Gelfond, Jonathan A. L.
    Scott, Nigel A.
    Abdel-Rahman, Susan M.
    Kearns, Gregory L.
    Burman, William J.
    Sterling, Timothy R.
    Villarino, M. Elsa
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2014, 3 (02) : 132 - 145
12345